Dr. Stephen Stahl, MD

NPI: 1710144167
Total Payments
$5.7M
2024 Payments
$47,980
Companies
32
Transactions
712

Payment Breakdown by Category

Other$4.9M (86.2%)
Consulting$629,601 (11.1%)
Travel$131,674 (2.3%)
Food & Beverage$13,991 (0.2%)
Education$2,423 (0.0%)
Gifts$295.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4.4M 149 77.9%
Consulting Fee $629,601 119 11.1%
Grant $379,008 4 6.7%
Travel and Lodging $131,674 238 2.3%
Honoraria $93,647 24 1.7%
Food and Beverage $13,991 164 0.2%
Education $2,423 8 0.0%
Gift $295.00 6 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $4.1M 77 $0 (2019)
Sunovion Pharmaceuticals Inc. $669,950 56 $0 (2022)
ACADIA Pharmaceuticals Inc $147,056 105 $0 (2021)
Alkermes, Inc. $108,666 80 $0 (2024)
H. Lundbeck A S $96,847 32 $0 (2023)
Teva Pharmaceuticals USA, Inc. $80,874 44 $0 (2022)
Otsuka America Pharmaceutical, Inc. $66,515 41 $0 (2023)
Allergan, Inc. $62,979 49 $0 (2020)
PFIZER INC. $48,481 7 $0 (2019)
AbbVie Inc. $46,866 39 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $47,980 39 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($28,436)
2023 $106,776 84 AbbVie Inc. ($45,494)
2022 $46,858 24 ITI, Inc. ($17,186)
2021 $91,330 35 CIPLA USA INC. ($20,000)
2020 $543,332 65 Sunovion Pharmaceuticals Inc. ($381,468)
2019 $544,141 133 Takeda Pharmaceuticals U.S.A., Inc. ($382,230)
2018 $1.8M 121 Takeda Pharmaceuticals U.S.A., Inc. ($1.6M)
2017 $2.5M 211 Takeda Pharmaceuticals U.S.A., Inc. ($2.1M)

All Payment Transactions

712 individual payment records from CMS Open Payments — Page 1 of 29

Date Company Product Nature Form Amount Type
12/16/2024 Alkermes, Inc. Consulting Fee Cash or cash equivalent $2,020.00 General
12/09/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,530.00 General
Category: Psychiatry/Psychology
11/27/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $125.00 General
11/18/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,383.00 General
11/14/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $4,977.00 General
10/21/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $707.63 General
10/07/2024 Alkermes, Inc. Consulting Fee Cash or cash equivalent $505.00 General
09/25/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Honoraria Cash or cash equivalent $1,140.00 General
Category: VILOXAZINE HYDROCHLORIDE
08/22/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Honoraria Cash or cash equivalent $1,140.00 General
Category: VILOXAZINE HYDROCHLORIDE
08/12/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $1,049.55 General
08/12/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $264.00 General
07/22/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: PSYCHIATRY
07/03/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. REXULTI (Drug) Education In-kind items and services $24.59 General
Category: PSYCHIATRY
07/03/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. REXULTI (Drug) Education In-kind items and services $24.59 General
Category: PSYCHIATRY
07/02/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $148.53 General
06/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Consulting Fee Cash or cash equivalent $4,800.00 General
Category: PSYCHIATRY
06/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $338.11 General
Category: PSYCHIATRY
06/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $338.11 General
Category: PSYCHIATRY
06/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $145.83 General
Category: PSYCHIATRY
06/24/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Consulting Fee Cash or cash equivalent $505.00 General
Category: CNS
06/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Consulting Fee Cash or cash equivalent $5,400.00 General
Category: PSYCHIATRY
06/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $262.38 General
Category: PSYCHIATRY
06/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $200.00 General
Category: PSYCHIATRY
06/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $125.00 General
Category: PSYCHIATRY
06/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Travel and Lodging In-kind items and services $125.00 General
Category: PSYCHIATRY

About Dr. Stephen Stahl, MD

Dr. Stephen Stahl, MD is a Specialist healthcare provider based in Carlsbad, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710144167.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Stahl, MD has received a total of $5.7M in payments from pharmaceutical and medical device companies, with $47,980 received in 2024. These payments were reported across 712 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4.4M).

Practice Information

  • Specialty Specialist
  • Location Carlsbad, CA
  • Active Since 05/21/2008
  • Last Updated 05/21/2008
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1710144167

Products in Payments

  • Trintellix (Drug) $2.4M
  • Latuda (Drug) $233,464
  • LATUDA (Drug) $208,810
  • SEP-225289 (Drug) $200,000
  • NUPLAZID (Drug) $131,114
  • VRAYLAR (Drug) $104,507
  • REXULTI (Drug) $85,804
  • AUSTEDO (Drug) $72,340
  • CAPLYTA (Drug) $66,316
  • BRINTELLIX (Drug) $36,939
  • CELEBREX (Drug) $32,573
  • ARISTADA (Drug) $24,708
  • ABILIFY MAINTENA (Drug) $19,915
  • LIPITOR (Drug) $15,908
  • CYMBALTA (Drug) $11,200
  • Vivitrol 380 mg (Drug) $10,350
  • SD809-TD (Drug) $7,443
  • Nuplazid (Drug) $6,892
  • LYBALVI (Drug) $6,633
  • DISEASE EDUCATION (Drug) $6,250

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Carlsbad